Fortis Advisors, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Fortis Advisors, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$50,930
+0.9%
5000.0%0.04%
+5.9%
Q2 2023$50,455
-45.2%
500
-50.0%
0.03%
-43.3%
Q1 2023$92,000
+1.4%
1,0000.0%0.06%
-13.0%
Q4 2022$90,720
+19.4%
1,0000.0%0.07%
+27.8%
Q3 2022$76,000
-10.6%
1,0000.0%0.05%
-3.6%
Q2 2022$85,000
-3.4%
1,0000.0%0.06%
+16.7%
Q1 2022$88,000
+1.1%
1,0000.0%0.05%
-4.0%
Q4 2021$87,000
+6.1%
1,0000.0%0.05%0.0%
Q3 2021$82,000
-9.9%
1,0000.0%0.05%
-5.7%
Q2 2021$91,000
+7.1%
1,0000.0%0.05%
-11.7%
Q1 2021$85,000
-9.6%
1,0000.0%0.06%
-27.7%
Q4 2020$94,000
+8.0%
1,0000.0%0.08%
+2.5%
Q3 2020$87,000
-66.8%
1,000
-66.7%
0.08%
-68.8%
Q2 2020$262,000
+2.3%
3,000
-3.5%
0.26%
+52.0%
Q1 2020$256,000
-12.9%
3,1100.0%0.17%
-3.9%
Q4 2019$294,000
+8.9%
3,1100.0%0.18%
+40.2%
Q3 2019$270,000
-1.5%
3,110
+3.7%
0.13%
-4.5%
Q2 2019$274,000
-4.9%
3,0000.0%0.13%
-11.9%
Q1 2019$288,000
+12.1%
3,0000.0%0.15%
-3.2%
Q4 2018$257,000
-0.4%
3,0000.0%0.16%
+7.6%
Q3 2018$258,000
+13.7%
3,0000.0%0.14%
+11.5%
Q2 2018$227,000
-6.6%
3,0000.0%0.13%
-3.0%
Q1 2018$243,000
-3.6%
3,0000.0%0.13%
-13.5%
Q4 2017$252,000
-2.3%
3,0000.0%0.16%
-13.4%
Q3 2017$258,000
+2.4%
3,000
-0.6%
0.18%
-8.7%
Q2 2017$252,000
+12.5%
3,0180.0%0.20%
-3.4%
Q1 2017$224,000
+2.3%
3,018
+0.6%
0.20%
-13.2%
Q4 2016$219,0003,0000.23%
Other shareholders
NOVARTIS A G shareholders Q1 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders